New York, NY, United States of America

Jeanne Allinne


Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • New York, NY (US) (2017 - 2020)
  • Port Chester, NY (US) (2020)
  • Paris, FR (2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovator Jeanne Allinne: Pioneering Advances in Biomedical Research

Introduction: Jeanne Allinne is a prominent inventor based in New York, NY, known for her groundbreaking contributions to biomedical research. With a portfolio that includes six patents, she has significantly impacted the field, especially in the treatment of disorders associated with interleukins.

Latest Patents: Among her recent innovations are two noteworthy patents:

1. **Anti-IL-25 antibodies and uses thereof** – This invention relates to antibodies that specifically bind human interleukin-25 (IL-25). These antibodies are designed to block IL-25-mediated cell signaling and are essential for treating various conditions such as asthma, allergy, chronic obstructive pulmonary disease (COPD), inflammatory bowel disease (IBD), atopic dermatitis, and Eosinophilic Granulomatosis with Polyangiitis (EGPA). The invention includes the development of fully human, non-naturally occurring antibodies that exhibit high affinity for IL-25.

2. **Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof** – This patent focuses on the identification of biomarkers that help in recognizing patients who are at risk of developing IL-33-mediated diseases and can benefit from treatment with IL-33 antagonists. The inventive methods provide strategies for monitoring therapy effectiveness and include approaches to reduce biomarker levels in patients suffering from relevant disorders.

Career Highlights: Jeanne Allinne has made significant strides in her career while working at Regeneron Pharmaceuticals, Inc. Her innovative work in antibody research and biomarkers has garnered her recognition in the field and has potential therapeutic applications for various diseases, illustrating her commitment to medical advancements.

Collaborations: Throughout her career, Jeanne has collaborated with esteemed colleagues, including Jamie M Orengo and Wen Fury. These collaborations have contributed to the rich exchange of ideas and innovations that drive research forward in her field.

Conclusion: Jeanne Allinne exemplifies the spirit of innovation through her impactful patents and collaborative work in biomedical research. Her contributions not only advance scientific understanding but also pave the way for new treatment options, addressing significant health challenges associated with interleukins. As she continues her work, the potential for further innovations remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…